Search

everythinglearnresearchcommunity

for

Search:↓

The study showed that a specific DNA sequence can control gene expression in hair growth areas of mice.

Tofacitinib is effective and safe for treating alopecia areata.

The document concludes that careful design of genetic fate mapping experiments is crucial for accurate cell lineage tracing in mice.

Kir6.1 mutations in Cantú syndrome increase channel sensitivity and hyperpolarization, while SUR2B mutations do not.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

The TRPV3 gene variant may cause the long-haired suri alpaca coat.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

The atlas maps maize peptides, showing complex regulation and varied roles across tissues and stages.

Aire mutation reduces alopecia areata, while Notch4 mutation prevents it in mice.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Tofacitinib effectively treats Alopecia Areata.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

Keratin-associated proteins help link filaments and affect keratin's strength.

Scientists found new, better-working inhibitors for a hormone-related enzyme.

The HtrA1L364P mutation causes brain dysfunction and blood vessel damage.

The C-allele and CC-genotype in the PTPN22 gene lower the risk of alopecia areata.

A specific gene change is linked to severe hair loss.

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

High TSPEAR levels in colorectal cancer predict worse outcomes.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Atoh1 expression can create new Merkel cells in the skin.

Tofacitinib effectively reduced hair loss in alopecia areata patients without adverse effects.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

TQC shows promise for better hair regrowth in treating hair loss.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

Transit-amplifying cells are crucial for tissue repair and can contribute to cancer when they malfunction.

Tofacitinib was more effective than methotrexate for treating alopecia areata.